Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension

Objectives: Postpartum stratification of cardiovascular risk for women with pregnancies complicated by pre-eclampsia is challenging. Our aim was to identify potential clinical and biomarker predictors of future cardiovascular risk at six weeks postpartum in women with hypertensive pregnancies. Stud...

Full description

Bibliographic Details
Main Authors: Escouto, Daniele Cristovao, Green, Amanda, Kurlak, Lesia, Walker, Kate, Loughna, Pamela, Chappell, Lucy, Broughton Pipkin, Fiona, Bramham, Kate
Format: Article
Language:English
Published: Elsevier 2018
Online Access:https://eprints.nottingham.ac.uk/52905/
_version_ 1848798837008760832
author Escouto, Daniele Cristovao
Green, Amanda
Kurlak, Lesia
Walker, Kate
Loughna, Pamela
Chappell, Lucy
Broughton Pipkin, Fiona
Bramham, Kate
author_facet Escouto, Daniele Cristovao
Green, Amanda
Kurlak, Lesia
Walker, Kate
Loughna, Pamela
Chappell, Lucy
Broughton Pipkin, Fiona
Bramham, Kate
author_sort Escouto, Daniele Cristovao
building Nottingham Research Data Repository
collection Online Access
description Objectives: Postpartum stratification of cardiovascular risk for women with pregnancies complicated by pre-eclampsia is challenging. Our aim was to identify potential clinical and biomarker predictors of future cardiovascular risk at six weeks postpartum in women with hypertensive pregnancies. Study design: Prospective longitudinal cohort. Main outcome measures: Ten year-Framingham cardiovascular risk scores were calculated for 477 women (94 with gestational hypertension, 288 with pre-eclampsia, 30 with superimposed pre-eclampsia, 51 with chronic hypertension, 14 women with uncomplicated pregnancies). B-type natriuretic peptide (BNP), neutrophil gelatinase–associated lipocalin (NGAL) and placental growth factor (PlGF) were quantified at six weeks postpartum. Results: Framingham cardiovascular risk scores were not higher in women with pregnancies complicated by pre-eclampsia than healthy controls, nor were scores higher in women with pre-existing chronic hypertension complicated with superimposed pre-eclampsia compared with those without superimposed pre-eclampsia. Women with gestational hypertension had higher risk scores than women with pre-eclampsia and healthy controls. Established risk factors of cardiovascular disease including diastolic blood pressure and previously diagnosed chronic hypertension were associated with higher scores, and African ethnicity, parity and estimated glomerular filtration rate also were independently associated with higher Framingham risk scores at six weeks postpartum. PlGF, BNP and NGAL concentrations were not associated with Framingham cardiovascular risk scores after adjustment for independent variables. Conclusions: A history of pre-eclampsia or superimposed pre-eclampsia in most recent pregnancy was not associated with elevated Framingham risk score at six weeks postpartum. Established clinical predictors may enable risk stratification at six weeks postpartum, which are not enhanced by the biomarkers included in this study.
first_indexed 2025-11-14T20:26:07Z
format Article
id nottingham-52905
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T20:26:07Z
publishDate 2018
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling nottingham-529052019-06-30T04:30:12Z https://eprints.nottingham.ac.uk/52905/ Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension Escouto, Daniele Cristovao Green, Amanda Kurlak, Lesia Walker, Kate Loughna, Pamela Chappell, Lucy Broughton Pipkin, Fiona Bramham, Kate Objectives: Postpartum stratification of cardiovascular risk for women with pregnancies complicated by pre-eclampsia is challenging. Our aim was to identify potential clinical and biomarker predictors of future cardiovascular risk at six weeks postpartum in women with hypertensive pregnancies. Study design: Prospective longitudinal cohort. Main outcome measures: Ten year-Framingham cardiovascular risk scores were calculated for 477 women (94 with gestational hypertension, 288 with pre-eclampsia, 30 with superimposed pre-eclampsia, 51 with chronic hypertension, 14 women with uncomplicated pregnancies). B-type natriuretic peptide (BNP), neutrophil gelatinase–associated lipocalin (NGAL) and placental growth factor (PlGF) were quantified at six weeks postpartum. Results: Framingham cardiovascular risk scores were not higher in women with pregnancies complicated by pre-eclampsia than healthy controls, nor were scores higher in women with pre-existing chronic hypertension complicated with superimposed pre-eclampsia compared with those without superimposed pre-eclampsia. Women with gestational hypertension had higher risk scores than women with pre-eclampsia and healthy controls. Established risk factors of cardiovascular disease including diastolic blood pressure and previously diagnosed chronic hypertension were associated with higher scores, and African ethnicity, parity and estimated glomerular filtration rate also were independently associated with higher Framingham risk scores at six weeks postpartum. PlGF, BNP and NGAL concentrations were not associated with Framingham cardiovascular risk scores after adjustment for independent variables. Conclusions: A history of pre-eclampsia or superimposed pre-eclampsia in most recent pregnancy was not associated with elevated Framingham risk score at six weeks postpartum. Established clinical predictors may enable risk stratification at six weeks postpartum, which are not enhanced by the biomarkers included in this study. Elsevier 2018-07-30 Article PeerReviewed application/pdf en cc_by_nc_nd https://eprints.nottingham.ac.uk/52905/7/Accepted%20Nottingham%20PDF%20Jul%202018.pdf Escouto, Daniele Cristovao, Green, Amanda, Kurlak, Lesia, Walker, Kate, Loughna, Pamela, Chappell, Lucy, Broughton Pipkin, Fiona and Bramham, Kate (2018) Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension. Pregnancy Hypertension, 13 . pp. 218-224. ISSN 2210-7789 https://www.sciencedirect.com/science/article/pii/S221077891830031X?via%3Dihub doi:10.1016/j.preghy.2018.06.019 doi:10.1016/j.preghy.2018.06.019
spellingShingle Escouto, Daniele Cristovao
Green, Amanda
Kurlak, Lesia
Walker, Kate
Loughna, Pamela
Chappell, Lucy
Broughton Pipkin, Fiona
Bramham, Kate
Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension
title Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension
title_full Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension
title_fullStr Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension
title_full_unstemmed Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension
title_short Postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension
title_sort postpartum evaluation of cardiovascular disease risk for women with pregnancies complicated by hypertension
url https://eprints.nottingham.ac.uk/52905/
https://eprints.nottingham.ac.uk/52905/
https://eprints.nottingham.ac.uk/52905/